Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
We were at the European Society of Cardiology Barcelona 22 congress at the end of August, where Borja Ibáñez, Director of the Clinical Research Department at Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and Coordinator of the RESILIENCE project discussed the role of cardiologist on the anthracycline-induced cardiotoxicity along with Teresa López Fernández, Head […]
